Reed R. Heimbecher

Dykema Gossett PLLC

Contact Info

Recently by Reed R. Heimbecher

Life Sciences

Biosimilars: Poised to Turn to Inter Partes Review to Resolve Patent Disputes

On March 6, 2015, the U.S. Food and Drug Administration (FDA) approved the first biosimilar drug in the U.S., Sandoz’s ZarxioTM, to treat cancer patients who are at increased risk for infection. A “biosimilar” is a biological product that is highly similar to an existing FDA‑...

Read More